Prognostic impact of biomarkers in PMBCL: rationale for early integration of immune checkpoint inhibitors
生物标志物在原发性纵隔大B细胞淋巴瘤(PMBCL)预后中的作用:早期整合免疫检查点抑制剂的理论依据
期刊:Exploration of Targeted Antitumor Therapy
影响因子:
doi:10.37349/etat.2025.1002318
Mangasarova, Yana K; Abdurashidova, Runiza R; Risinskaya, Natalya V; Biderman, Bella V; Abramova, Tatiana V; Surin, Vadim L; Shupletsova, Irina A; Obukhova, Tatiana N; Iusupov, Rasul I; Chabaeva, Yulia A; Magomedova, Aminat U; Nikulina, Lena E; Kulikov, Sergei M; Zvonkov, Eugene E; Kovrigina, Alla M; Sudarikov, Andrey B